(Q24240080)

1

0 references

Shing Shun N Siu

2

0 references

David Luesley

3

0 references

Andrew Bryant

Cochrane Database of Systematic Reviews

4

0 references

publication date

7 October 2009

0 references

published in

0 references

cites work

FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007583.PUB2

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007583.PUB2

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007583.PUB2

EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007583.PUB2

Primary management of early stage cervical cancer (IA1-IB) and appropriate selection of adjuvant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007583.PUB2

Significance of postoperative irradiation in carcinoma of the cervix: a ten year survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007583.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007583.PUB2

Management of cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007583.PUB2

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007583.PUB2

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007583.PUB2

Adjuvant chemotherapy for early stage cervix cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007583.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007583.PUB2

Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007583.PUB2

Chemotherapy versus radiotherapy versus observation for high-risk cervical carcinoma after radical hysterectomy: A randomized, prospective, multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007583.PUB2

7 January 2021

A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007583.PUB2

7 January 2021

A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007583.PUB2

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD007583.PUB2

1 reference

7 January 2021

Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007583.PUB2

7 January 2021